Running title: Wearable multimodal motor seizure detectors Onorati et al. 2 Summary Objective:New devices are needed for monitoring seizures, especially those associated with sudden unexpected death in epilepsy (SUDEP). They must be unobtrusive, automated and provide false alarm rates bearable in everyday life. This study quantifies the performance of new multimodal wrist-worn convulsive seizure detectors. Methods:Hand-annotated video-electroencephalography seizure events were collected from 69 patients at 6 clinical sites. Three different wristbands were used to record electrodermal activity (EDA) and accelerometer (ACM) signals, obtaining 5,928 hours of data, including 55 convulsive epileptic seizures (6 focal tonic-clonic seizures and 49 focal-to-bilateral-tonicclonic seizures) from 22 patients. Recordings were analyzed off-line to train and test two new machine learning classifiers and a published EDA and ACM-based classifier. Moreover, wristband data were analyzed to estimate seizure-motion duration and autonomic responses. Results:The two novel classifiers consistently outperformed the previous detector. The most efficient (Classifier III) yielded sensitivity of 94.55%, and false alarm rate (FAR) of 0.2 events/day.No nocturnal seizures were missed. Most patients had less than 1 false alarm every 4 days with FAR below their seizure frequency. When increasing the sensitivity to 100% (no missed seizures) the FAR is up to 13 times lower than the previous detector. Furthermore, all detections occurred before the seizure ended, providing reasonable latency (median: 29.3 s, range: 14.8-151 s). Automatically estimated seizure durations were correlated with true durations, enabling reliable annotations. Finally, EDA measurements confirmed the presence of post-ictal autonomic dysfunction, exhibiting a significant rise in 73% of the convulsive seizures. Onorati et al. 3 Significance:The proposed multimodal wrist-worn convulsive seizure detectors provide seizure counts that are more accurate than previous automated detectors and typical patient self-reports, while maintaining a tolerable FAR for ambulatory monitoring. Furthermore, the multimodal system provides an objective description of motor behaviour and autonomic dysfunction, aimed at enriching seizure characterization, with potential utility for SUDEP warning.
We construct some cusped finite-volume hyperbolic n-manifolds Mn that fiber algebraically in all the dimensions 5 ≤ n ≤ 8. That is, there is a surjective homomorphism π 1 (Mn) → Z with finitely generated kernel.The kernel is also finitely presented in the dimensions n = 7, 8, and this leads to the first examples of hyperbolic n-manifolds Mn whose fundamental group is finitely presented but not of finite type. These n-manifolds Mn have infinitely many cusps of maximal rank and hence infinite Betti number b n−1 . They cover the finite-volume manifold Mn.We obtain these examples by assigning some appropriate colours and states to a family of right-angled hyperbolic polytopes P 5 , . . . , P 8 , and then applying some arguments of Jankiewicz -Norin -Wise [15] and . We exploit in an essential way the remarkable properties of the Gosset polytopes dual to Pn, and the algebra of integral octonions for the crucial dimensions n = 7, 8.
The work considers automatic sleep stage classification, based on heart rate variability (HRV) analysis, with a focus on the distinction of wakefulness (WAKE) from sleep and rapid eye movement (REM) from non-REM (NREM) sleep. A set of 20 automatically annotated one-night polysomnographic recordings was considered, and artificial neural networks were selected for classification. For each inter-heartbeat (RR) series, beside features previously presented in literature, we introduced a set of four parameters related to signal regularity. RR series of three different lengths were considered (corresponding to 2, 6, and 10 successive epochs, 30 s each, in the same sleep stage). Two sets of only four features captured 99 % of the data variance in each classification problem, and both of them contained one of the new regularity features proposed. The accuracy of classification for REM versus NREM (68.4 %, 2 epochs; 83.8 %, 10 epochs) was higher than when distinguishing WAKE versus SLEEP (67.6 %, 2 epochs; 71.3 %, 10 epochs). Also, the reliability parameter (Cohens's Kappa) was higher (0.68 and 0.45, respectively). Sleep staging classification based on HRV was still less precise than other staging methods, employing a larger variety of signals collected during polysomnographic studies. However, cheap and unobtrusive HRV-only sleep classification proved sufficiently precise for a wide range of applications.
This study presents different methods for automatic sleep classification based on heart rate variability (HRV), respiration and movement signals recorded through bed sensors. Two methods for feature extraction have been implemented: time variant-autoregressive model (TVAM) and wavelet discrete transform (WDT); the obtained features are fed into two classifiers: Quadratic (QD) and Linear (LD) discriminant for staging sleep in REM, nonREM and WAKE periods. The performances of all the possible combinations of feature extractors and classifiers are compared in terms of accuracy and kappa index, using clinical polysomographyc evaluation as golden standard. 17 recordings from healthy subjects, including also polisomnography, were used to train and test the algorithms. When automatic classification is compared. QD-TVAM algorithm achieved a total accuracy of 76.81 ± 7.51 % and kappa index of 0.55 ± 0.10, while LD-WDT achieved a total accuracy of 79 ± 10% and kappa index of 0.51 ± 0.17. The results suggest that a good sleep evaluation can be achieved through non-conventional recording systems that could be used outside sleep centers.
The aim of the study is to define physiological parameters and vital signs that may be related to the mood and mental status in patients affected by bipolar disorder. In particular we explored the autonomic nervous system through the analysis of the heart rate variability. Many different parameters, in the time and in the frequency domain, linear and non-linear were evaluated during the sleep in a group of normal subject and in one patient in four different conditions. The recording of the signals was performed through a wearable sensorized T-shirt. Heart rate variability (HRV) signal and movement analysis allowed also obtaining sleep staging and the estimation of REM sleep percentage over the total sleep time. A group of eight normal females constituted the control group, on which normality ranges were estimated. The pathologic subject was recorded during four different nights, at time intervals of at least 1 week, and during different phases of the disturbance. Some of the examined parameters (MEANNN, SDNN, RMSSD) confirmed reduced HRV in depression and bipolar disorder. REM sleep percentage was found to be increased. Lempel–Ziv complexity and sample entropy, on the other hand, seem to correlate with the depression level. Even if the number of examined subjects is still small, and the results need further validation, the proposed methodology and the calculated parameters seem promising tools for the monitoring of mood changes in psychiatric disorders.
The aim of this study is to identify parameters extracted from the Heart Rate Variability (HRV) signal that correlate to the clinical state in patients affected by bipolar disorder. 25 ECG and activity recordings from 12 patients were obtained by means of a sensorized T-shirt and the clinical state of the subjects was assessed by a psychiatrist. Features in the time and frequency domain were extracted from each signal. HRV features were also used to automatically compute the sleep profile of each subject by means of an Artificial Neural Network, trained on a control group of healthy subjects. From the hypnograms, sleep-specific parameters were computed. All the parameters were compared with those computed on the control group, in order to highlight significant differences in their values during different stages of the pathology. The analysis was performed by grouping the subjects first on the basis of the depression-mania level and then on the basis of the anxiety level.
Lempel-Ziv Complexity (LZC) has been demonstrated to be a powerful complexity measure in several biomedical applications. During sleep, it is still not clear how many samples are required to ensure robustness of its estimate when computed on beat-to-beat interval series (RR). The aims of this study were: i) evaluation of the number of necessary samples in different sleep stages for a reliable estimation of LZC; ii) evaluation of the LZC when considering inter-subject variability; and iii) comparison between LZC and Sample Entropy (SampEn). Both synthetic and real data were employed. In particular, synthetic RR signals were generated by means of AR models fitted on real data. The minimum number of samples required by LZC for having no changes in its average value, for both NREM and REM sleep periods, was 10(4) (p<;0.01) when using a binary quantization. However, LZC can be computed with N >1000 when a tolerance of 5% is considered satisfying. The influence of the inter-subject variability on the LZC was first assessed on model generated data confirming what found (>10(4); p<;0.01) for both NREM and REM stage. However, on real data, without differentiate between sleep stages, the minimum number of samples required was 1.8×10(4). The linear correlation between LZC and SampEn was computed on a synthetic dataset. We obtained a correlation higher than 0.75 (p<;0.01) when considering sleep stages separately, and higher than 0.90 (p<;0.01) when stages were not differentiated. Summarizing, we suggest to use LZC with the binary quantization and at least 1000 samples when a variation smaller than 5% is considered satisfying, or at least 10(4) for maximal accuracy. The use of more than 2 levels of quantization is not recommended.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.